RESPONSE TO VEMURAFENIB-COBIMETINIB WITH REDUCED DOSES IN A PATIENT WITH METASTASIC MELANOMA: CONCERNING A CASE

RESPONSE TO VEMURAFENIB-COBIMETINIB WITH REDUCED DOSES IN A PATIENT WITH METASTASIC MELANOMA: CONCERNING A CASE